Skip to main content
Journal cover image

Adaptive stereotactic body radiation therapy planning for lung cancer.

Publication ,  Journal Article
Qin, Y; Zhang, F; Yoo, DS; Kelsey, CR; Yin, F-F; Cai, J
Published in: Int J Radiat Oncol Biol Phys
September 1, 2013

PURPOSE: To investigate the dosimetric effects of adaptive planning on lung stereotactic body radiation therapy (SBRT). METHODS AND MATERIALS: Forty of 66 consecutive lung SBRT patients were selected for a retrospective adaptive planning study. CBCT images acquired at each fraction were used for treatment planning. Adaptive plans were created using the same planning parameters as the original CT-based plan, with the goal to achieve comparable comformality index (CI). For each patient, 2 cumulative plans, nonadaptive plan (PNON) and adaptive plan (PADP), were generated and compared for the following organs-at-risks (OARs): cord, esophagus, chest wall, and the lungs. Dosimetric comparison was performed between PNON and PADP for all 40 patients. Correlations were evaluated between changes in dosimetric metrics induced by adaptive planning and potential impacting factors, including tumor-to-OAR distances (dT-OAR), initial internal target volume (ITV1), ITV change (ΔITV), and effective ITV diameter change (ΔdITV). RESULTS: 34 (85%) patients showed ITV decrease and 6 (15%) patients showed ITV increase throughout the course of lung SBRT. Percentage ITV change ranged from -59.6% to 13.0%, with a mean (±SD) of -21.0% (±21.4%). On average of all patients, PADP resulted in significantly (P=0 to .045) lower values for all dosimetric metrics. ΔdITV/dT-OAR was found to correlate with changes in dose to 5 cc (ΔD5cc) of esophagus (r=0.61) and dose to 30 cc (ΔD30cc) of chest wall (r=0.81). Stronger correlations between ΔdITV/dT-OAR and ΔD30cc of chest wall were discovered for peripheral (r=0.81) and central (r=0.84) tumors, respectively. CONCLUSIONS: Dosimetric effects of adaptive lung SBRT planning depend upon target volume changes and tumor-to-OAR distances. Adaptive lung SBRT can potentially reduce dose to adjacent OARs if patients present large tumor volume shrinkage during the treatment.

Duke Scholars

Published In

Int J Radiat Oncol Biol Phys

DOI

EISSN

1879-355X

Publication Date

September 1, 2013

Volume

87

Issue

1

Start / End Page

209 / 215

Location

United States

Related Subject Headings

  • Tumor Burden
  • Thoracic Wall
  • Spinal Cord
  • Retrospective Studies
  • Radiotherapy Planning, Computer-Assisted
  • Radiosurgery
  • Organs at Risk
  • Oncology & Carcinogenesis
  • Middle Aged
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Qin, Y., Zhang, F., Yoo, D. S., Kelsey, C. R., Yin, F.-F., & Cai, J. (2013). Adaptive stereotactic body radiation therapy planning for lung cancer. Int J Radiat Oncol Biol Phys, 87(1), 209–215. https://doi.org/10.1016/j.ijrobp.2013.05.008
Qin, Yujiao, Fan Zhang, David S. Yoo, Chris R. Kelsey, Fang-Fang Yin, and Jing Cai. “Adaptive stereotactic body radiation therapy planning for lung cancer.Int J Radiat Oncol Biol Phys 87, no. 1 (September 1, 2013): 209–15. https://doi.org/10.1016/j.ijrobp.2013.05.008.
Qin Y, Zhang F, Yoo DS, Kelsey CR, Yin F-F, Cai J. Adaptive stereotactic body radiation therapy planning for lung cancer. Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):209–15.
Qin, Yujiao, et al. “Adaptive stereotactic body radiation therapy planning for lung cancer.Int J Radiat Oncol Biol Phys, vol. 87, no. 1, Sept. 2013, pp. 209–15. Pubmed, doi:10.1016/j.ijrobp.2013.05.008.
Qin Y, Zhang F, Yoo DS, Kelsey CR, Yin F-F, Cai J. Adaptive stereotactic body radiation therapy planning for lung cancer. Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):209–215.
Journal cover image

Published In

Int J Radiat Oncol Biol Phys

DOI

EISSN

1879-355X

Publication Date

September 1, 2013

Volume

87

Issue

1

Start / End Page

209 / 215

Location

United States

Related Subject Headings

  • Tumor Burden
  • Thoracic Wall
  • Spinal Cord
  • Retrospective Studies
  • Radiotherapy Planning, Computer-Assisted
  • Radiosurgery
  • Organs at Risk
  • Oncology & Carcinogenesis
  • Middle Aged
  • Male